期刊
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
卷 29, 期 7, 页码 1080-1086出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.108.180760
关键词
cerebral aneurysm; collagen; procollagen; lysyl oxidase; inflammation
资金
- Ministry of Education, Science, and Culture of Japan [17390399]
- Grants-in-Aid for Scientific Research [17390399] Funding Source: KAKEN
Background-Reduced extracellular matrix is a prominent feature of cerebral aneurysms (CAs). We previously reported excessive ECM degradation in CA walls. In the present study, we examined collagen biosynthesis in CA walls and the molecular mechanisms underlying it in CA progression. Methods and Results-RT-PCR and immunohistochemistry showed reduced expression of procollagen type I, III, and lysyl oxidase (LOX) in CA walls. Treatment with the LOX inhibitor beta-aminopropionitrile resulted in enhanced progression of CA. Expression of procollagen type I, III, and LOX was inhibited by interleukin-1 beta (IL-1 beta) in cultured rat aortic smooth muscle cells (RASMCs) in vitro. Nuclear factor kappa-B (NF-kappa B) was activated in IL-1 beta-stimulated RASMCs, and treatment with NF-kappa B decoy oligodeoxynucleotides (ODN) restored reduced expression of procollagen type I, III, and LOX in vitro. NF-kappa B decoy ODNs ameliorated the expression of procollagen type I, III, and LOX in CA walls in vivo. Conclusions-Collagen biosynthesis was significantly inhibited at the transcriptional level and in the posttranscriptional enzymatic modification in CA walls through upregulated expression of IL-1 beta and the NF-kappa B pathway. Reduced collagen biosynthesis may contribute to CA progression, and inhibition of this process may lead to the prevention of the progression and rupture of CAs. (Arterioscler Thromb Vasc Biol. 2009; 29: 1080-1086.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据